跳至主要内容
临床试验/CTRI/2022/01/039714
CTRI/2022/01/039714招募中4 期

A prospective, multi-center, single arm, post-marketing study to evaluate the safety and efficacy of Ovine Forestomach Matrix (OFM) products (Endoformâ?¢ Natural Dermal Template; Endoformâ?¢ Antimicrobial Dermal Template and Myriad Matrixâ?¢) in acute or chronic wound. - NA

Aroa Biosurgery Limited0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
招募中

研究概览

简要总结

暂无简介。

研究设计

研究类型
Pms

入排标准

入选标准

  • Patients will be considered eligible for the study based on the following criteria:
  • 1. Willing and able to provide written informed consent and to comply with the requirements of Clinical Investigational Plan
  • 2. Male or female patients aged 18 years or above
  • 3. Patients with acute or chronic full thickness wounds, including deep partial burns

排除标准

  • Patients will be excluded from the study based on the following criteria:
  • 1. Patients with known sensitivity to ovine (sheep) derived material
  • 2. Patients with known sensitivity to ionic silver
  • 3. Patients with third degree burns
  • 4. Patients with wounds with uncontrolled clinical infection (CDC Contamination Grade equal to 4), acute inflammation, excessive exudate, or bleeding
  • 5. Any medical condition or serious intercurrent illness that, in the opinion of the investigator, may make it undesirable for the patient to participate in the study
  • 6. Patient is currently participating or has participated in another clinical study within past 30 days prior to enrollment
  • 7. Pregnant or lactating women
  • 8. Patients with suspected signs and symptoms of COVID-19 Or confirmed novel coronavirus infection (COVID-19)

研究者

相似试验

Study to evaluate the safety and efficacy of Ovine... | 临床试验